Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Serge Basile Nouemssi has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Isabel Desgagné-Penix

    Department of Biochemistry, Chemistry, Physics, and Forensic Science, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada

    6 shared publications
  • Fatma Meddeb-Mouelhi

    Department of Biochemistry, Chemistry, Physics, and Forensic Science, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada

    4 shared publications
  • Manel Ghribi

    Department of Biochemistry, Chemistry, Physics, and Forensic Science, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada

    3 shared publications
  • Rémy Beauchemin

    Department of Biochemistry, Chemistry, Physics, and Forensic Science, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada

    3 shared publications
  • Alexandre Custeau

    Department of Biochemistry, Chemistry, Physics, and Forensic Science, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada

    2 shared publications
  • Hugo Germain

    Université du Québec à Trois-Rivières

    2 shared publications

Latest Publications

  • Open Access

    Functional Expression of Cannabis sativa Polyketide Enzymes in Chlamydomonas reinhardtii Reveals Metabolic Constraints to Olivetolic Acid Accumulation

    by Bharat Bhusan Majhi, Karen Cristine Gonçalves dos Santos, Rémy Beauchemin, Serge Basile Nouemssi, Daris Pazhukkunnel Simon, Manel Ghribi, Alexandre Custeau, Sarah-Eve Gélinas, Fatma Meddeb-Mouelhi, Isabel Desgagné-Penix

    Plant specialized metabolites are valuable sources of pharmaceuticals, nutraceuticals, and industrial compounds. Transferring their biosynthetic pathways into microbial hosts remains a major challenge, particularly in photosynthetic microalgae. Here, we investigated the ability of the green microalga Chlamydomonas reinhardtii to functionally express Cannabis sativa polyketide biosynthetic enzymes involved in olivetolic acid synthesis, a key intermediate in cannabinoid biosynthesis. Nuclear transformants carrying the C. sativa tetraketide synthase (CsTKS) and olivetolic acid cyclase (CsOAC) genes were generated. Functional enzyme activity was confirmed by in vitro enzymatic assays using total protein extracts. In vitro olivetolic acid production was detected, verified, and quantified by high-performance liquid chromatography and liquid chromatography–tandem mass spectrometry using authentic standards. However, in vivo olivetolic acid and downstream metabolites were not detected in algal biomass. This indicated that functional enzyme expression did not result in productive intracellular pathway flux. Untargeted metabolomic profiling revealed extensive metabolic rewiring and strain-specific metabolic perturbations following pathway introduction. These findings suggest that heterologous pathway expression triggered broad physiological responses. This study demonstrates that plant polyketide enzymes remain catalytically active in C. reinhardtii; however, intrinsic metabolic and cellular constraints limit in vivo metabolite accumulation. These findings provide important insights into the biological barriers that limit the functional implementation of plant polyketide pathways in photosynthetic microalgae C. reinhardtii and identify key targets for future metabolic and cellular engineering.

  • Open Access

    Functional Expression of the Aromatic Prenyltransferase NphB in Chlamydomonas reinhardtii Highlights Challenges in Cannabinoid Biocatalysis

    by Serge Basile Nouemssi, Ayoub Bouhadada, Rémy Beauchemin, Alexandre Custeau, Sarah-Ève Gélinas, Natacha Merindol, Fatma Meddeb-Mouelhi, Hugo Germain, Isabel Desgagné-Penix

    Cannabinoids are high-value bioactive compounds whose sustainable production remains challenging, prompting interest in biocatalytic and microbial platforms as alternatives to plant extraction. In this study, we investigated the heterologous expression and functionality of two key cannabinoid-related enzymes in the photosynthetic microalga Chlamydomonas reinhardtii: the aromatic prenyltransferase, NphBG286S/Y288A from Streptomyces sp., and the plant-derived cannabidiolic acid synthase (CBDAS) from Cannabis sativa. Codon-optimized genes were introduced into the nuclear genome of C. reinhardtii using several construct configurations and promoters, and stable transformants were generated and characterized for genomic integration, transcript accumulation, protein production, enzymatic activity, and cannabinoid-related metabolite formation. While NphB protein accumulation was achieved under the PSAD promoter control, CBDAS was not detected at the protein level under any condition tested. In vitro enzymatic assays using soluble algal protein extracts from NphB-expressing lines confirmed catalytic activity, yielding cannabigerolic acid (CBGA), reaching up to 633 ± 58 µg L−1. However, no CBGA production was detected in vivo, despite substrate supplementation. These results indicate that, although bacterial prenyltransferase can be functionally expressed in C. reinhardtii, efficient metabolic conversion in vivo is limited by cellular and biochemical constraints, including substrate availability, intracellular compartmentalization, and potential competition with endogenous pathways. In contrast, the absence of detectable CBDAS highlights the challenges associated with expressing complex plant oxidocyclases in this photosynthetic host. Overall, this work provides mechanistic insights into enzyme compatibility and metabolic bottlenecks in microalgal systems and outlines key considerations for the future development of photosynthetic platforms for cannabinoid biocatalysis.


  • Open Access

    Successful reversal of transgene silencing in Chlamydomonas reinhardtii

    by Rémy Beauchemin, Natacha Merindol, Elisa Fantino, Pamela Lavoie, Serge Basile Nouemssi, Fatma Meddeb‐Mouelhi, Isabel Desgagné‐Penix

    Chlamydomonas reinhardtii has been successfully engineered to produce compounds of interest following transgene integration and heterologous protein expression. The advantages of this model include the availability of validated tools for bioengineering, its photosynthetic ability, and its potential use as biofuel. Despite this, breakthroughs have been hindered by its ability to silence transgene expression through epigenetic changes. Histone deacetylases (HDAC) are main players in gene expression. We hypothesized that transgene silencing can be reverted with chemical treatments using HDAC inhibitors. To analyze this, we transformed C. reinhardtii, integrating into its genome the mVenus reporter gene under the HSP70‐rbcs2 promoter. From 384 transformed clones, 88 (22.9%) displayed mVenus positive (mVenus+) cells upon flow‐cytometry analysis. Five clones with different fluorescence intensities were selected. The number of integrated copies was measured by qPCR. Transgene expression levels were followed over the growth cycle and upon SAHA treatment, using a microplate reader, flow cytometry, RT‐qPCR, and western blot analysis. First, we observed that expression varies with the cell cycle, reaching a maximum level just before the stationary phase in all clones. Second, we uncovered that supplementation with HDAC inhibitors of the hydroxamate family, such as vorinostat (suberoylanilide‐hydroxamic‐acid, SAHA) at the initiation of culture increases the frequency (% of mVenus+ cells) and the level of transgene expression per cell over the whole growth cycle, through histone deacetylase inhibition. Thus, we propose a new tool to successfully trigger the expression of heterologous proteins in the green algae C. reinhardtii, overcoming its main obstacle as an expression platform.


  • Open Access

    Successful reversal of transgene silencing in Chlamydomonas reinhardtii

    by Remy Beauchemin, Natacha Mérindol, Elisa I. Fantino, Pamela Lavoie, Serge Basile Nouemssi, Fatma Meddeb-Mouelhi, Isabel Desgagné-Penix

    Chlamydomonas reinhardtii has been successfully engineered to produce compounds of interest following transgene integration and heterologous protein expression. The advantages of this model include the availability of validated tools for bioengineering, its photosynthetic ability and its potential use as biofuel. Despite this, breakthroughs have been hindered by its ability to silence transgene expression through epigenetic changes. Histone deacetylases (HDAC) are main players in gene expression. We hypothesized that transgene silencing can be reverted with chemical treatments using HDAC inhibitors. To analyze this, we transformed C. reinhardtii, integrating into its genome the mVenus reporter gene under the HSP70-rbcs2 promoter. From 384 transformed clones, 88 (22.9 %) displayed mVenus positive (mVenus+) cells upon flow-cytometry analysis. Five clones with different fluorescence intensities were selected. The number of integrated copies was measured by qPCR. Transgene expression levels were followed over the growth cycle and upon SAHA treatment, using a microplate reader, flow cytometry, RT-qPCR, and western blot analysis. First, we observed that expression varies with the cell cycle, reaching a maximum level just before the stationary phase in all clones. Second, we uncovered that supplementation with HDAC inhibitors of the hydroxamate family, such as vorinostat (suberoylanilide-hydroxamic-acid, SAHA) at the initiation of culture increases the frequency (% of mVenus+ cells) and the level of transgene expression per cell over the whole growth cycle, through histone deacetylase inhibition. Thus, we propose a new tool to successfully trigger the expression of heterologous proteins in the green algae C. reinhardtii, overcoming its main handicap as an expression platform.

  • Open Access

    Genome Editing by CRISPR-Cas: A Game Change in the Genetic Manipulation of Chlamydomonas

    by Manel Ghribi, Serge Basile Nouemssi, Fatma Meddeb-Mouelhi, Isabel Desgagné-Penix

    Microalgae are promising photosynthetic unicellular eukaryotes among the most abundant on the planet and are considered as alternative sustainable resources for various industrial applications. Chlamydomonas is an emerging model for microalgae to be manipulated by multiple biotechnological tools in order to produce high-value bioproducts such as biofuels, bioactive peptides, pigments, nutraceuticals, and medicines. Specifically, Chlamydomonas reinhardtii has become a subject of different genetic-editing techniques adapted to modulate the production of microalgal metabolites. The main nuclear genome-editing tools available today include zinc finger nucleases (ZFNs), transcriptional activator-like effector nucleases (TALENs), and more recently discovered the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) nuclease system. The latter, shown to have an interesting editing capacity, has become an essential tool for genome editing. In this review, we highlight the available literature on the methods and the applications of CRISPR-Cas for C. reinhardtii genetic engineering, including recent transformation methods, most used bioinformatic tools, best strategies for the expression of Cas protein and sgRNA, the CRISPR-Cas mediated gene knock-in/knock-out strategies, and finally the literature related to CRISPR expression and modification approaches.


  • Open Access

    Rapid and Efficient Colony-PCR for High Throughput Screening of Genetically Transformed Chlamydomonas reinhardtii

    by Serge Basile Nouemssi, Manel Ghribi, Rémy Beauchemin, Fatma Meddeb-Mouelhi, Hugo Germain, Isabel Desgagné-Penix

    Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and biotechnological development is focused on genetic engineering of microalgae to open up future economic opportunities for food, fuel and pharmacological production. Colony-polymerase chain reaction (colony-PCR or cPCR) is a critical method for screening genetically transformed microalgae cells. However, the ability to rapidly screen thousands of transformants using the current colony-PCR method, becomes a very laborious and time-consuming process. Herein, the non-homologous transformation of Chlamydomonas reinhardtii using the electroporation and glass beads methods generated more than seven thousand transformants. In order to manage this impressive number of clones efficiently, we developed a high-throughput screening (HTS) cPCR method to rapidly maximize the detection and selection of positively transformed clones. For this, we optimized the Chlamydomonas transformed cell layout on the culture media to improve genomic DNA extraction and cPCR in 96-well plate. The application of this optimized HTS cPCR method offers a rapid, less expensive and reliable method for the detection and selection of microalgae transformants. Our method, which saves up to 80% of the experimental time, holds promise for evaluating genetically transformed cells and selection for microalgae-based biotechnological applications such as synthetic biology and metabolic engineering.